Athira Pharma, Inc. (ATHA)
NASDAQ
Market Cap
$92.37M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
104 of 809
Rank in Industry
74 of 445
Largest Insider Buys in Sector
ATHA Stock Price History Chart
ATHA Stock Performance
About Athira Pharma, Inc.
Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical trials for the treatment of Alzheimer's disease, as well as is in Phase 2 clinical trials to treat Parkinson's disease. It also develops product candidates, which are in preclinical stage, including ATH-1019 for peripheral nervous system indications; and ATH-1020 for neuropsychiatric conditions. Athira Pharma, Inc. was formerly known as M3 Biotechnology, Inc. and changed its name to Athira Pharma, Inc. in April 2019. The company was incorporated in 2011 and is headquartered in Bothell, Washington.
Insider Activity of Athira Pharma, Inc.
Over the last 12 months, insiders at Athira Pharma, Inc. have bought $1.56M and sold $38,598 worth of Athira Pharma, Inc. stock.
On average, over the past 5 years, insiders at Athira Pharma, Inc. have bought $28.64M and sold $34,306 worth of stock each year.
Highest buying activity among insiders over the last 12 months: PERCEPTIVE ADVISORS LLC () — $24.87M. Romano Kelly A (director) — $100,051.
The last purchase of 27,400 shares for transaction amount of $66,179 was made by Romano Kelly A (director) on 2024‑06‑24.
List of Insider Buy and Sell Transactions, Athira Pharma, Inc.
| 2024-06-24 | Romano Kelly A | director | 27,400 0.0729% | $2.42 | $66,179 | -7.59% | ||
| 2024-06-21 | Romano Kelly A | director | 15,000 0.0347% | $2.26 | $33,872 | -2.56% | ||
| 2024-01-05 | Sale | Litton Mark James | Chief Executive Officer | 4,820 0.0129% | $2.91 | $14,026 | -10.45% | |
| 2024-01-05 | Sale | Gengos Andrew | CFO AND CHIEF BUSINESS OFFICER | 1,208 0.0032% | $2.91 | $3,515 | -10.45% | |
| 2024-01-05 | Sale | CHURCH KEVIN | CHIEF SCIENTIFIC OFFICER | 2,412 0.0065% | $2.91 | $7,019 | -10.45% | |
| 2024-01-05 | Sale | Worthington Mark | General Counsel | 2,412 0.0065% | $2.91 | $7,019 | -10.45% | |
| 2024-01-05 | Sale | Lenington Rachel | Chief Operating Officer | 2,412 0.0065% | $2.91 | $7,019 | -10.45% | |
| 2023-12-29 | PERCEPTIVE ADVISORS LLC | 163,954 0.4272% | $2.38 | $390,211 | +7.50% | |||
| 2023-12-28 | PERCEPTIVE ADVISORS LLC | 409,598 1.0852% | $2.44 | $999,419 | +5.10% | |||
| 2023-12-27 | PERCEPTIVE ADVISORS LLC | 32,134 0.0833% | $2.28 | $73,266 | +11.74% | |||
| 2023-06-07 | Gengos Andrew | See Below | 15,000 0.0378% | $3.43 | $51,445 | -29.80% | ||
| 2023-06-05 | Gengos Andrew | See Below | 45,000 0.1184% | $3.00 | $135,150 | -16.28% | ||
| 2023-06-02 | Gengos Andrew | See Below | 20,012 0.0493% | $2.82 | $56,422 | -16.56% | ||
| 2023-03-30 | PICKERING GRANT | director | 15,000 0.0397% | $2.47 | $37,050 | +10.16% | ||
| 2023-03-29 | PICKERING GRANT | director | 10,000 0.0259% | $2.33 | $23,300 | +14.13% | ||
| 2023-03-29 | JOHNSON JAMES A | director | 5,000 0.0134% | $2.40 | $12,000 | +14.13% | ||
| 2023-01-05 | Sale | Gengos Andrew | See Below | 1,208 0.0027% | $2.91 | $3,515 | ||
| 2023-01-05 | Sale | CHURCH KEVIN | Chief Scientific Officer | 2,412 0.0054% | $2.91 | $7,019 | ||
| 2022-12-28 | MILESON GLENNA | Chief Financial Officer | 50,000 0.1327% | $2.85 | $142,250 | -4.49% | ||
| 2022-12-02 | Romano Kelly A | director | 30,000 0.0797% | $3.29 | $98,700 | -14.63% |
Insider Historical Profitability
<0.0001%
| PERCEPTIVE ADVISORS LLC | 5402964 14.1979% | $2.41 | 5 | 0 | <0.0001% | |
| Litton Mark James | Chief Executive Officer | 144397 0.3794% | $2.41 | 0 | 2 | |
| CHURCH KEVIN | Chief Scientific Officer | 80256 0.2109% | $2.41 | 0 | 3 | |
| Gengos Andrew | See Below | 83804 0.2103% | $2.41 | 3 | 2 | <0.0001% |
| Romano Kelly A | director | 80715 0.1007% | $2.41 | 4 | 0 | <0.0001% |
| Worthington Mark | General Counsel | 34452 0.0905% | $2.41 | 0 | 2 | |
| Lenington Rachel | Chief Operating Officer | 13395 0.0352% | $2.41 | 0 | 2 | |
| EDELMAN JOSEPH | 3695916 9.7121% | $2.41 | 2 | 0 | +8.83% | |
| RTW INVESTMENTS, LP | 10 percent owner | 2668913 7.0134% | $2.41 | 1 | 0 | +9% |
| MILESON GLENNA | Chief Financial Officer | 159930 0.4203% | $2.41 | 1 | 1 | <0.0001% |
| MOEBIUS HANS | Chief Medical Officer | 65836 0.173% | $2.41 | 2 | 0 | +2.03% |
| PICKERING GRANT | director | 25783 0.0678% | $2.41 | 2 | 0 | +12.15% |
| JOHNSON JAMES A | director | 5000 0.0131% | $2.41 | 1 | 0 | +14.14% |
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
| Perceptive Advisors | $14.8M | 14.1 | 5.4M | 0% | +$0 | 0.01 | |
| Baker Bros Advisors LP | $8.64M | 8.23 | 3.15M | 0% | +$0 | 0.11 | |
| The Vanguard Group | $4.48M | 4.26 | 1.63M | -3.77% | -$175,414.82 | <0.0001 | |
| Simplify Asset Management Inc | $4.09M | 3.9 | 1.49M | 0% | +$0 | 0.39 | |
| Bml Capital Management Llc | $2.47M | 2.35 | 900,000 | -38.12% | -$1.52M | 1.88 | |
| Tang Capital Management, LLC | $2.34M | 2.23 | 852,715 | -26.03% | -$821,999.96 | 0.01 | |
| BlackRock | $1.83M | 1.74 | 667,278 | +0.7% | +$12,647.84 | <0.0001 | |
| Acadian Asset Management | $1.5M | 1.44 | 549,938 | +281.52% | +$1.11M | 0.01 | |
| Jacobs Levy Equity Management | $1.36M | 1.3 | 497,475 | +84.12% | +$622,741.95 | 0.01 | |
| Dimensional Fund Advisors | $1.2M | 1.14 | 438,594 | +26.47% | +$251,504.48 | <0.0001 | |
| Two Sigma | $1.17M | 1.11 | 425,605 | +39.97% | +$333,003.25 | <0.01 | |
| Two Sigma Advisers LP | $1.01M | 0.96 | 369,500 | +23.74% | +$194,266.00 | <0.01 | |
| Geode Capital Management | $822,866.00 | 0.78 | 300,237 | +5.97% | +$46,345.60 | <0.0001 | |
| Renaissance Technologies | $719,000.00 | 0.68 | 262,324 | -1.16% | -$8,430.96 | <0.01 | |
| Bank of America | $625,821.00 | 0.6 | 228,402 | +369.04% | +$492,394.06 | <0.0001 | |
| Nan Fung Group | $493,200.00 | 0.47 | 180,000 | 0% | +$0 | 0.54 | |
| Gsa Capital Partners Llp | $483,000.00 | 0.46 | 176,230 | -41.42% | -$341,553.33 | 0.04 | |
| Bridgeway Capital Management | $482,166.00 | 0.46 | 175,973 | -17.02% | -$98,914.00 | 0.01 | |
| Advisor Group Holdings Inc | $448,234.00 | 0.43 | 163,589 | -3.77% | -$17,579.85 | <0.01 | |
| Laird Norton Trust Company Llc | $403,627.00 | 0.38 | 147,309 | -47.82% | -$369,900.31 | 0.05 | |
| Jane Street Capital | $402,150.00 | 0.38 | 146,770 | +544.35% | +$339,738.25 | <0.0001 | |
| Millennium Management LLC | $388,151.00 | 0.37 | 141,661 | -68.92% | -$860,896.73 | <0.0001 | |
| Barclays | $361,000.00 | 0.34 | 131,666 | -24.17% | -$115,086.47 | <0.0001 | |
| Citadel Advisors LLC | $296,232.00 | 0.28 | 108,114 | -1.79% | -$5,408.75 | <0.0001 | |
| State Street | $295,320.00 | 0.28 | 107,781 | 0% | +$0 | <0.0001 | |
| Susquehanna International Group | $255,974.00 | 0.24 | 93,421 | +89.97% | +$121,226.04 | <0.0001 | |
| Bristlecone Advisors Llc | $233,739.00 | 0.22 | 85,306 | 0% | +$0 | 0.02 | |
| Cornercap Investment Counsel Inc | $206,566.00 | 0.2 | 75,389 | 0% | +$0 | 0.03 | |
| Clarius Group Llc | $146,730.00 | 0.14 | 53,551 | 0% | +$0 | 0.01 | |
| Northern Trust | $145,823.00 | 0.14 | 53,220 | -1.92% | -$2,849.60 | <0.0001 | |
| Morgan Stanley | $116,447.00 | 0.11 | 42,499 | -14.25% | -$19,355.32 | <0.0001 | |
| Occudo Quantitative Strategies Lp | $115,296.00 | 0.11 | 42,079 | +170.45% | +$72,664.51 | 0.02 | |
| Bailard Inc | $110,896.00 | 0.11 | 40,473 | New | +$110,896.00 | <0.01 | |
| Goldman Sachs | $109,740.00 | 0.1 | 40,051 | New | +$109,740.00 | <0.0001 | |
| Blair William Co Il | $98,763.00 | 0.09 | 36,045 | 0% | +$0 | <0.0001 | |
| American Century Investments | $97,563.00 | 0.09 | 35,607 | +133.2% | +$55,726.02 | <0.0001 | |
| Levin Easterly Partners Llc | $91,790.00 | 0.09 | 33,500 | <0.01% | -$2.74 | 0.01 | |
| Integrity Financial Corp Wa | $89,834.00 | 0.09 | 32,786 | 0% | +$0 | 0.07 | |
| Brighton Jones | $88,228.00 | 0.08 | 32,200 | 0% | +$0 | <0.01 | |
| OMERS | $66,308.00 | 0.06 | 24,200 | New | +$66,308.00 | <0.01 | |
| Prelude Capital | $64,848.00 | 0.06 | 23,667 | -24.68% | -$21,248.84 | 0.01 | |
| Qube Research & Technologies | $58,302.00 | 0.06 | 21,278 | +3,646.13% | +$56,745.67 | <0.0001 | |
| Forefront Analytics | $56,488.00 | 0.05 | 20,616 | -30.74% | -$25,068.33 | 0.03 | |
| Simon Quick Advisors, LLC | $56,274.00 | 0.05 | 20,538 | 0% | +$0 | <0.01 | |
| Mirador Capital Partners | $56,608.00 | 0.05 | 20,660 | New | +$56,608.00 | 0.01 | |
| Journey Strategic Wealth Llc | $56,274.00 | 0.05 | 20,538 | 0% | +$0 | <0.01 | |
| Sargent Investment Group Llc | $54,123.00 | 0.05 | 19,753 | +8.51% | +$4,244.24 | 0.01 | |
| Ameriprise Financial | $50,057.00 | 0.05 | 18,269 | New | +$50,057.00 | <0.0001 | |
| Simplex Trading Llc | $50,000.00 | 0.05 | 18,325 | New | +$50,000.00 | <0.01 | |
| Point72 Asia Singapore Pte Ltd | $48,632.00 | 0.05 | 17,749 | +477.2% | +$40,206.54 | 0.01 |